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Susceptibility of clinical isolates
of bacteria to cefamandole,
cefoxitin and cephalothin
R. del Busto, M D ; A. Suarez, M D ;
E. Quinn, M D , and D. Pohlod, M.S.

T HE cephalosporin antibiotics have a wide
spectrum of activity against gram positive
and gram negative bacteria. However, certain Enterobacteriaceae such as Serrada, Enterobacter and indole positive Proteus are
resistant to the c o m m e r c i a l l y available
cephalosporins. This resistance is related, at
least in part, to the susceptibility of the
antibiotics to hydrolysis by the/3-lactamases
produced by these gram negative organisms.'-^ In the case of Pseudomonas
aeruginosa the resistance to ;8-lactam antibiotics seems to be primarily due to an intrinsic
resistance rather than to /S-lactamase.^

The in vitro susceptibility was determined
of 274 isolates to cephalothin and two new
antibiotics,
cefamandole
and
cefoxitin.
Cefamandole
was comparable
to cephalothin in preventing growth of cultures
of the gram positive organisms except for
penicillin-resistant
Staphylococcus aureus
which was more sensitive to cephalothin.
Cefamandole
was more active
than
cephalothin against all the gram negative
bacteria including Haemophilus
influenzae
and in addition it was active against many
strains of Enterobacter sp. Cefoxitin was less
active than cephalothin against the gram
positive organisms but It was more active
against most of the gram negative bacteria.
In addition. It was active against Serratiaand
indole positive Proteus which are uniformly
resistant to cephalothin.

Two investigational antibiotics: cefamandole, a new cephalosporin and cefoxitin, a
cephamycin derivative, have been shown to
have a wider spectrum of activity against
gram negative organisms than the currently
available cephalosporins."^' In addition,
cefoxitin is also active against Bacteroides
fragllis w h i c h is usually resistant to the
cephalosporin antibiotics." Cefoxitin has an
increased resistance to inactivation by the ;Slactamase of certain gram negative bacteria
probably related to the presence of an alpha
methoxy group in position C7 of its lactam
ring' (Figure 1).

* Division of Infectious Diseases, Department of
Medicine

The purpose of this study was to compare
the in vitro activity of cefamandole and
cefoxitin with that of cephalothin against
recent isolates of bacteria from Henry Ford
Hospital.

Address reprint requests to Dr. del Busto at Henry
Ford Hospital, 2799 West Grand Boulevard, Detroit Ml 48202
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Disc susceptibility testing was done according to the standardized disc technique
recommended by the Food and Drug Administration.'^-'^ Thirty microgram discs
were used for the three antibiotics. The zone
diameters were then plotted against the MIC
values obtained with the agar dilution method, and a regression line was calculated by
the method of least squares.
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Results and discussion

COO" Na+

Tablel compares the MlC'sand the zones
of inhibition of the three antibiotics against
the gram positive organisms tested. It can be
seen that cefamandole was as active as
cephalothin against all of them except penicillin resistant 5. aureus which was more
sensitive to cephalothin. Cefoxitin was less
active than cephalothin against all the gram
positive organisms tested. All three antibiotics were inactive against S. faecalls.

Figure 1
Chemical structure of cephalothin and cefoxitin.

Material and methods
The activity of cefamandole, cefoxitin and
cephalothin against 274 isolates was determined by the agar dilution method'" utilizingMueller-Hinton agar (BBL), except in the
case of Haemophilus influenzae where GC
Medium Base (BBL)was used. Inoculation of
the agar plates, containingtwofold dilutions
of the antibiotics, was performed using the
Steers replicator." Approximately 10' organisms were delivered to each plate for each
representative organ ism. The minimal inhibitory concentration (MIC) was defined as the
lowest concentration of antibiotic which
prevented visible growth after 18 hours of
incubation (24 hours for H. influenzae) at
37°C. The susceptibility of the following
bacteria was determined: 39 strains of £scherichia coli (including 19 cephalothinresistant strains), 24 strains each of penicillin
resistantStaphy/ococcus aureus, Proteus m i rabllls, Klebsiella sp., and Streptococcus
faecalls, 23 strains of P. aeruginosa, 22
strainsof group A beta hemolytic streptococcus, 20 strains of penicillin sensitive Stap h y l o c o c c u s aureus, 18 strains of alpha
streptococcus, 15 strains each of indole positive Proteus and H. influenzae, 14 strains of
Enterobacter sp., and 12 of Serratia sp.

Table 2 compares theMlC's and the zones
of inhibition of the three antibiotics against
the gram negative organisms. Cefamandole
was more active than cephalothin against all
the gram negative bacteria including H.
influenzae, and in addition it was active
against many strains of Enterobacter
sp.
Cefamandole was more active than cefoxitin
against all the gram negative bacteria except
Serratia sp. and indole positive Proteus.
Cefoxitin
compared
favorably
with
cephalthin and in addition it was active
against Serrada sp. and indole positive Proteus. All three antibiotics
were
inactive
against P. aeruginosa.
Figures 2 to 8 show the activity ofthe three
antibiotics against some of the organisms
tested, expressed as cumulative percent of
strains inhibited at increasing MIC's. One
hundred percent of strains of group A beta
hemolytic streptococcus were inhibited by
0.048 Mg/ml of cefamandole, 0.39 p.g/m\
of cephalothin and 0.78 /u.g/ml of cefoxitin
(Figure 2). All strainsof penicillin resistantS.
aureus were inhibited by 0.39 p g / m \ of
cephalothin, whereas 3.1 / i g / m l of cefa-
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Table 1.
In Vitro Activity of Cefamandole, Cefoxitin and
Cephalothin Against G r a m Positive Organisms
Cefamandole

MIC

Cefoxitin

Cephalothin

Organisms and
Number of Strains

(yag/ml)

Group A hemolytic
streptococcus (22)

<0.033

41.8

0.625

34.0

<0.075

34.9

S. aureus
Penicillin res. (24)
Penicillin sen. (20)

0.984
0.209

27.6
40.2

3.51
2.61

29.2
30.1

0.329
0.193

31.3
39.5

0.143

43.9

1.82

32.7

0.389

37.7

Alpha streptococcus (18)
S. faecalls (24)

34.3

Zone of
MIC
Inhibition" (/uig/ml)
(mm)

12.9

Zone of
Inhibition
(mm)

50.0

MIC
(/ag/ml)

6

25,C

Zone of
Inhibition
(mm)

14.9

'Geometric mean
"Arithmetic mean

Table 2.
In Vitro Activity of Cefamandole, Cefoxitin and
Cephalothin Against Gram Negative Organisms
Cefamandole
Organisms and
Number of Strains
E. coli (20
Klebsiella sp. (24)
Enterobacter sp (14)
P. mirabilis (24)
Indole positive
Proteus (15)
Serratia sp. (12)
P. aeruginosa (23)
H. influenzae (15)

MIC
(Mg/ml)

Cefoxitin

Zone of
MIC
Inhibition'' {pglmi)
(mm)

Cephalothin

Zone of
Inhibition
(mm)

MIC
{pglm\)

Zone of
Inbibition
(mm)

0.984
1.43
7.99
0.989

26.5
25.5
23.4
28.2

3.71
4.95
>33.6
2.77

26.1
22.8
10.6
23.9

8.47
4.60
>50
5.14

17.6
21.4
6.0
24.5

>17.3
>26.5
>50
0.389

16.5
14.9
6.0
26.2

8.63
18.7
>50
6.84

19.3
17.6
6.0
21.1

>50
>50
>50
1.70

6.0
6.0
6.0
23.1

'Geometric mean
"Arithmetic mean

mandole and 6.2 /ag/ml of cefoxitin were
needed to inhibit all strains (Figure 3).

tested 19 strains of cephalothin resistant E.
coli {not shown in the graph), and found that
both cefamandole and cefoxitin inhibited
about50% of them at a concentration of 12.5
p g / m l . This concentration can be readily
achieved with doses of cefamandole and
cefoxitin recommended in current clinical
trials. Previous studies have shown that the

Against E. coll, a concentration of 1.56
p g / m l of cefamandole inhibited 90% of
strains, whereas at the same concentration,
only about 20% of strains were inhibited by
cephalothin and cefoxitin (Figure 4). We also
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Figure 2
Cumulative percentage of group A hemolytic streptococcus inhibited by increasing concentrations of
cefamandole, cefoxitin and cephalothin.
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Figure 3
Cumulative percentage of penicillin resistant S. aureus inhibited by increasing concentrations of
cefamandole, cefoxitin and cephalothin.
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Figure 4
Cumulative percentage o f f . coli inhibited by increasing concentrations of cefamandole, cefoxitin and
cephalothin.
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Figure 5
Cumulative percentage of Enterobacter sp. inhibited by increasing concentrations of cefamandole,
cefoxitin and cephalothin.

63

del Busto, Suarez, Quinn and Pohlod

12.5

6.2

25

ANTIBIOTIC CONCENTRATION

50

>50

(^g/ml)

Figure 6
Cumulative percentage of Serratia sp. inhibited by increasing concentrations of cefamandole, cefoxitin
and cephalothin.
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Figure 7
Cumulative percentage of indole positiveProfeus inhibited by increasing concentrations of cefamandole,
cefoxitin and cephalothin.
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Figure 8
Cumulative percentage of H. influenzae inhibited by increasing concentrations of cefamandole, cefoxitin
and cephalothin.

peak serum levels of c e f a m a n d o l e and
c e f o x i t i n are c o m p a r a b l e to those of
cephalothin and their serum half lives are
more prolonged.^-^"''^

half of the strains and cephalothin none of
them (Figure 7). All strains of H. influenzae
were inhibited by 12.5 p g / m l or less of the
three antibiotics. However, cefamandole
was much more active, and at a concentration of less than 1 p g / m l , it inhibited all
strains (Figure 8).

Against Enterobacter sp., cefamandole at
a concentration of 12.5 p g / r n l inhibited
70% of strains, whereas cefoxitin inhibited
15% and cephalothin inhibited none of them
(Figure 5). AgainstSerrat/a sp., cefoxitin was
the most active antibiotic, and at a concentration of 12.5 p g / m l , itinhibited 60% of
strains while cefamandole inhibited only
15% and cephalothin was uniformly inactive
(Figure 6). Cefoxitin was also the most active
against indole positive Proteus; at a concentration of 12.5/ag/ml it inhibited 85% of
strains, while cefamandole inhibited only

Disc susceptibility tests: Using the established criteria for all cephalosporin antibiotics (i.e., that a zone of inhibition of 18 mm or
more, with a 30 p g antibiotic disc, indicates
susceptibility) we found that all the gram
positive organ isms tested (excepts, faecalls)
were susceptible to the three antibiotics.
With the gram negative organisms, however,
we found that 72% of the isolates were
sensitive to cefoxitin, 68% to cefamandole
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Figure 9
Regression line correlating disc zone sizes with MIC's of cefamandole.

and cefoxitin asdetermined bythe standardized disc technique and the agar dilution
method is shown in Figures 9 and 10. The
regression curve for cefamandole shows that
the accepted cutoff point for susceptibil ity of
the cephalosporins (18 mm), corresponds to
an MIC value of 10 p g / m l (Figure 9). For
cefoxitin an 18 mm inhibition zone corresponds to an MIC of 12.5 / i g / ml. It should be

and only 47% were sensitive to cephalothin.
The greater number of susceptible organisms
to cefoxitin and cefamandole was related
mainly to the increased susceptibility of
Serratia sp. indole positive Proteus, Enterobacter sp. and E. coli.

The correlation of activity of cefamandole
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Figure 10
Regression line correlating disc zone sizes with MIC's of cefoxitin.

kept in mind, however, that before establishinga zone diameter and MIC value to define
susceptibility of an organism to any antibiotic, we must await the results of clinical trials
with the antibiotic.
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In conclusion, this study demonstrates
that cefamandole and cefoxitin have an
increased in vitro activity as compared to
cephalothin, especially against the gram
negative bacteria. This data indicates that
clinical trials with these two new antibiotics
are warranted.
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